Talaris Therapeutics to Present at the Jefferies Healthcare Conference
May 31 2022 - 7:00AM
Talaris Therapeutics, Inc. (Nasdaq: TALS), a late-clinical stage
cell therapy company developing therapies with the potential to
transform the standard of care in solid organ transplantation and
severe immune and blood disorders, today announced that Scott
Requadt, Chief Executive Officer of Talaris, will present at the
Jefferies Healthcare Conference on Wednesday, June 8, 2022 at 10:30
AM ET at the Marriott Marquis in New York, NY.
A live webcast of the fireside chat will be available on the
investors section of the Talaris website at www.talaristx.com.
After the live webcast, the event will remain archived on the
Talaris website for 30 days.
About Talaris TherapeuticsTalaris Therapeutics,
Inc. is a late-clinical stage cell therapy company developing
therapies with the potential to transform the standard of care in
solid organ transplantation and severe immune and blood disorders.
Talaris maintains corporate offices in Boston, MA, its cell
processing facility in Louisville, KY, and additional research
operations in Houston, TX.
Media ContactLisa RaffenspergerTen Bridge
Communicationslisa@tenbridgecommunications.com(617)
903-8783
Investor ContactChris BrinzeyICR
Westwickechris.brinzey@westwicke.com(339)
970-2843
Talaris Therapeutics (NASDAQ:TALS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Talaris Therapeutics (NASDAQ:TALS)
Historical Stock Chart
From Apr 2023 to Apr 2024